A prospective multi-faceted interventional study of blood bank technologist screening of red blood cell transfusion orders: The START study.

BACKGROUND: Transfusion of red blood cells (RBC) is a common procedure, which when prescribed inappropriately can result in adverse patient outcomes. This study sought to determine the impact of a multi-faceted intervention on unnecessary RBC transfusions at hospitals with a baseline appropriateness below 90%. STUDY DESIGN AND METHODS: A prospective medical chart audit of RBC transfusions was conducted across 15 hospitals. For each site, 10 RBCs per month transfused to inpatients were audited for a 5-month pre- and 10-month post-intervention period, with each transfusion adjudicated for appropriateness based on pre-set criteria. Hospitals with appropriateness rates below 90% underwent a 3-month intervention which included: adoption of standardized RBC guidelines, staff education, and prospective transfusion order screening by blood bank technologists. Proportions of RBC transfusions adjudicated as appropriate and the total number of RBC units transfused per month in the pre- and post-intervention period were examined. RESULTS: Over the 15-month audit period, at the 13 hospital sites with a baseline appropriateness below 90%, 1950 patients were audited of which 81.2% were adjudicated as appropriate. Proportions of appropriateness and single-unit orders increased from 73.5% to 85% and 46.2% to 68.2%, respectively from pre- to post-intervention (P < .0001). Pre- and post-transfusion hemoglobin levels and the total number of RBCs transfused decreased from baseline (P < .05). The median pre-transfusion hemoglobin decreased from a baseline of 72.0 g/L to 69.0 g/L in the post-intervention period (P < .0001). RBC transfusions per acute inpatient days decreased significantly in intervention hospitals, but not in control hospitals (P < .001). The intervention had no impact on patient length of stay, need for intensive care support, or in-hospital mortality. CONCLUSION: This multifaceted intervention demonstrated a marked improvement in RBC transfusion appropriateness and reduced overall RBC utilization without impacts on patient safety.

A randomized comparison between double-injection and targeted intracluster-injection ultrasound-guided supraclavicular brachial plexus block.

BACKGROUND: In this prospective, randomized, observer-blinded study, we compared double-injection (DI) ultrasound-guided supraclavicular block to a novel targeted intracluster-injection (TII) technique, whereby local anesthetic is injected inside the main and satellite neural clusters (confluences of trunks and divisions of the brachial plexus). METHODS: Ninety patients were randomly allocated to receive a DI (n = 45) or TII (n = 45) technique for ultrasound-guided supraclavicular block. The local anesthetic drug (lidocaine 1.5% with epinephrine 5 µg/mL) and total volume (32 mL) were identical in all subjects. In both groups, half the volume (16 mL) was injected inside the main neural cluster. For the DI technique, the second half (16 mL) was deposited at the "corner pocket" (intersection of the first rib and subclavian artery). In contrast, for the TII technique, the remaining half was divided into equal aliquots and injected inside every single satellite cluster. The main outcome variable was the total anesthesia-related time (sum of performance and onset times). RESULTS: Due to a quicker onset (mean ± standard deviation (SD): 10.1 ± 6.4 vs 18.5 ± 8.3 minutes; P < 0.0001), the total anesthesia-related time was shorter with the TII technique (21.2 ± 7.7 vs 27.7 ± 9.0 minutes; P = 0.001; 95% confidence interval for the difference of the means: 2.90-10.08 minutes). There were 0 (of 45) and 3 (of 45) surgical failures for the TII and DI group, respectively. Thus, the 2 methods achieved comparable rates of surgical anesthesia (93.3%-100.0%; 95% confidence interval for the difference of the success rates: -2.3% to 17.9%). No intergroup differences were observed in block-related pain scores and adverse events. The DI group required fewer needle passes (median ± interquartile range: 4 ± 2 vs 7 ± 3; P < 0.0001) as well as shorter needling (8.4 ± 2.9 vs 10.7 ± 2.7 minutes; P < 0.0001) and performance (9.0 ± 3.2 vs 11.2 ± 3.0 minutes; P = 0.001) times. CONCLUSION: Although DI and TII ultrasound-guided supraclavicular blocks seem to provide comparable success rates, we cannot exclude the possibility that an intergroup difference of 17.9% might have gone undetected. Due to its quick onset, the TII technique results in a shorter total anesthesia-related time.

Myofascial pain in patients waitlisted for total knee arthroplasty.

BACKGROUND: Knee pain is one of the major sources of pain and disability in developed countries, particularly in aging populations, and is the primary indication for total knee arthroplasty (TKA) in patients with osteoarthritis (OA). OBJECTIVES: To determine the presence of myofascial pain in OA patients waitlisted for TKA and to determine whether their knee pain may be alleviated by trigger point injections. METHODS: Following ethics approval, 25 participants were recruited from the wait list for elective unilateral primary TKA at the study centre. After providing informed consent, all participants were examined for the presence of active trigger points in the muscles surrounding the knee and received trigger point injections of bupivacaine. Assessments and trigger point injections were implemented on the first visit and at subsequent visits on weeks 1, 2, 4 and 8. Outcome measures included the Timed Up and Go test, Brief Pain Inventory, Centre for Epidemiologic Studies Depression Scale, State-Trait Anxiety Inventory and Short-Form McGill Pain Questionnaire. RESULTS: Myofascial trigger points were identified in all participants. Trigger point injections significantly reduced pain intensity and pain interference, and improved mobility. All participants had trigger points identified in medial muscles, most commonly in the head of the gastrocnemius muscle. An acute reduction in pain and improved functionality was observed immediately following intervention, and persisted over the eight-week course of the investigation. CONCLUSION: All patients had trigger points in the vastus and gastrocnemius muscles, and 92% of patients experienced significant pain relief with trigger point injections at the first visit, indicating that a significant proportion of the OA knee pain was myofascial in origin. Further investigation is warranted to determine the prevalence of myofascial pain and whether treatment delays or prevents TKA.

Minimum effective volume of combined lidocaine-bupivacaine for analgesic subparaneural popliteal sciatic nerve block.

BACKGROUND AND OBJECTIVES: The aim of this study was to determine the minimum effective volume (MEV) of combined lidocaine 1.0%-bupivacaine 0.25% with epinephrine 5 µg/mL in 90% of patients (MEV90) for ultrasound-guided subparaneural popliteal sciatic nerve block. METHODS: All subjects received an ultrasound-guided subparaneural popliteal sciatic nerve block (at the neural bifurcation) with combined lidocaine 1.0%-bupivacaine 0.25% and epinephrine 5 µg/mL. Using an out-of-plane technique, a 17-gauge, 8-cm Tuohy needle was advanced until its tip was positioned between the tibial and peroneal nerves inside the paraneural sheath. Volume assignment was carried out using a biased coin design, up-and-down sequential method, where the volume of local anesthetic administered to each patient depended on the response of the previous one. In case of failure, the next subject received a higher volume (defined as the previous volume with an increment of 3.0 mL). If the previous patient had a successful block, the next subject was randomized to a lower volume (defined as the previous volume with a decrement of 3.0 mL), with a probability of b = 0.11, or the same volume, with a probability of 1 - b = 0.89. Using a composite scale encompassing sensory and motor block, success was defined, at 30 minutes, as a minimal score of 6 points (out of 8 points). The 6-point score was intended to mirror successful postoperative analgesia. Patients undergoing surgery of the leg, ankle, or foot were prospectively enrolled until 45 successful blocks were obtained. RESULTS: Fifty-two patients were recruited for this study. Using isotonic regression and bootstrap confidence interval, the MEV90 of combined lidocaine 1.0%-bupivacaine 0.25% with epinephrine 5 µg/mL was estimated to be 13.3 mL (95% confidence interval, 10.2-16.4 mL). CONCLUSIONS: For ultrasound-guided subparaneural (analgesic) popliteal sciatic nerve block, the MEV90 of combined lidocaine 1.0%-bupivacaine 0.25% with epinephrine 5 µg/mL is 13.3 mL (95% confidence interval, 10.2-16.4 mL).